Compare CSV & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | ARVN |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 678.1M | 781.0M |
| IPO Year | 1996 | 2018 |
| Metric | CSV | ARVN |
|---|---|---|
| Price | $45.25 | $13.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 21 |
| Target Price | ★ $59.00 | $15.57 |
| AVG Volume (30 Days) | 78.4K | ★ 722.7K |
| Earning Date | 06-01-2026 | 05-27-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | 54.76 | ★ 58.84 |
| EPS | ★ 3.25 | N/A |
| Revenue | ★ $417,440,000.00 | $262,600,000.00 |
| Revenue This Year | $7.05 | N/A |
| Revenue Next Year | $4.16 | N/A |
| P/E Ratio | $14.02 | ★ N/A |
| Revenue Growth | ★ 3.28 | N/A |
| 52 Week Low | $35.51 | $5.90 |
| 52 Week High | $49.41 | $18.93 |
| Indicator | CSV | ARVN |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 61.23 |
| Support Level | $43.58 | $11.07 |
| Resistance Level | $46.06 | $13.97 |
| Average True Range (ATR) | 1.33 | 0.82 |
| MACD | 0.12 | 0.13 |
| Stochastic Oscillator | 60.14 | 94.37 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.